Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge
- PMID: 23728703
- PMCID: PMC10846371
- DOI: 10.1002/14651858.ED000058
Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge
References
-
- Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408–12. doi.org/10.1001/jama.1995.03520290060030 - PubMed
-
- Lundh A, Gøtzsche PC. Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Medical Research Methodology 2008;8:22. doi.org/10.1186/1471‐2288‐8‐22 - PMC - PubMed
-
- Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291(20):2457–65. doi.org/10.1001/jama.291.20.2457 - PubMed
-
- Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. doi.org/10.1136/bmj.d5928 - PMC - PubMed
-
- Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Krebs Seida J, et al. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 2009;339:b4012. doi.org/10.1136/bmj.b4012 - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources